9,091
edits
Changes
Jump to navigation
Jump to search
Line 2,005:
Line 2,005: − + − + − + Line 2,023:
Line 2,023: + + + + + + + + + + + Line 2,031:
Line 2,042: − +
→Management of diseases (Treatment protocols)
Main drugs:
Main drugs:
#Guduchi
#''Guduchi''
#Kokilaksha
#''Kokilaksha''
#Suranjana
#''Suranjana''
{| class="wikitable"
{| class="wikitable"
| ''Kokilaksha kwatha'' + ghee + honey
| ''Kokilaksha kwatha'' + ghee + honey
|-
|-
| ''Pittaja'' and ''Raktaja''
| ''Mauktika kamduha''
| 60-250 mg
| Between two meals
| Milk and ''guduchi kwatha''
|-
| ''Kaphaja''
| ''Gud-Bhallataka-haritaki vati''
| 1-3 grams
| Before meals, two times
| Milk or lukewarm water
|}
|}
A research on ''vatarakta'' concluded that the notion of ''margavarana'' (obstruction in pathway) can be correlated to the pathology of atherosclerosis, and the state of ''uttana vatarakta'' to that of peripheral arterial disease. Identical therapeutic efficacy of ''kaishora guggulu'' and ''amrita guggulu'' was observed in thirty patients of ''uttana vatarakta''.
A research on ''vatarakta'' concluded that the notion of ''margavarana'' (obstruction in pathway) can be correlated to the pathology of atherosclerosis, and the state of ''uttana vatarakta'' to that of peripheral arterial disease. Identical therapeutic efficacy of ''kaishora guggulu'' and ''amrita guggulu'' was observed in thirty patients of ''uttana vatarakta''.
Another study was carried out to evaluate the antioxidant effect of five ''kashayams'' (''kwaths'' - decoctions) ''manjishtadi kashayam'' (MK), ''rasna erandadi kashayam'' (REK), ''sahacharadhi kashayam'' (SK), ''maharasnadi'' (or ''rasna dwiguna bhagam'') ''kashayam'' (MRK) and ''dhanwantharam kashayam'' (DK) used in the management of diseases manifested due to vitiation of ''vata'' and ''vatarakta'' (mostly diseases of connective tissues, bones, joints and nervous system). It concluded that the total phenolic content and the antioxidant property of the products justify the protective and corrective effects produced by the products in ''vata'' and ''vatarakta'' disorders. The phenolic content is highest in MK, followed by DK. The phenolic content of MRK, SK and REK are comparable. This shows the formulations act by scavenging the free radicals in rheumatic diseases.
Another study was carried out to evaluate the antioxidant effect of five ''kashayams'' (''kwaths'' - decoctions) ''manjishtadi kashayam'' (MK), ''rasna erandadi kashayam'' (REK), ''sahacharadhi kashayam'' (SK), ''maharasnadi'' (or ''rasna dwiguna bhagam'') ''kashayam'' (MRK) and ''dhanwantharam kashayam'' (DK) used in the management of diseases manifested due to vitiation of ''vata'' and ''vatarakta'' (mostly diseases of connective tissues, bones, joints and nervous system). It concluded that the total phenolic content and the antioxidant property of the products justify the protective and corrective effects produced by the products in ''vata'' and ''vatarakta'' disorders. The phenolic content is highest in MK, followed by DK. The phenolic content of MRK, SK and REK are comparable. This shows the formulations act by scavenging the free radicals in rheumatic diseases.
==== Potential areas /scope for further research ====
==== Potential areas /scope for further research ====